Identification of novel PTPRQ phosphatase inhibitors based on the virtual screening with docking simulations
Author:
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Modeling and Simulation
Link
http://link.springer.com/content/pdf/10.1186/1742-4682-10-49.pdf
Reference21 articles.
1. Heneberg P: Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs. Curr Med Chem. 2009, 16: 706-733. 10.2174/092986709787458407.
2. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T: Protein tyrosine phosphatases in the human genome. Cell. 2004, 117: 699-711. 10.1016/j.cell.2004.05.018.
3. Tonks NK: Protein tyrosine phosphatases – from housekeeping enzymes to master regulators of signal transduction. FEBS J. 2013, 280: 346-378. 10.1111/febs.12077.
4. Seifert RA, Coats SA, Oganesian A, Wright MB, Dishmon M, Booth CJ, Johnson RJ, Alpers CE, Bowen-Pope DF: PTPRQ is a novel phosphatidylinositol phosphatase that can be expressed as a cytoplasmic protein or as a subcellularly localized receptor-like protein. Exp Cell Res. 2003, 287: 374-386. 10.1016/S0014-4827(03)00121-6.
5. Oganesian A, Poot M, Daum G, Coats SA, Wright MB, Seifert RA, Bowen-Pope DF: Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation. Proc Natl Acad Sci U S A. 2003, 100: 7563-7568. 10.1073/pnas.1336511100.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Protein Tyrosine Phosphatase Receptor-type Q: Structure, Activity, and Implications in Human Disease;Protein & Peptide Letters;2022-07
2. In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications—A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B;Molecules;2021-01-10
3. Docking Screens for Novel Ligands Conferring New Biology;Journal of Medicinal Chemistry;2016-03-15
4. Discovery of Novel DUSP16 Phosphatase Inhibitors through Virtual Screening with Homology Modeled Protein Structure;Journal of Biomolecular Screening;2014-09-22
5. Discovery of Novel DUSP4 Inhibitors through the Virtual Screening with Docking Simulations;Bulletin of the Korean Chemical Society;2014-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3